The
in situ reverse transcription-polymerase chain reaction (
in situ RT-PCR) method has been used to detect low levels of expression of mRNA in cells and tissues. We applied a newly developed
in situ RT-PCR to cells and quantitatively compared the sensitivity of the
in situ RT-PCR with that of conventional
in situ hybridization (ISH). Human tumor cell lines with either high, moderate, low or no expression of IL-6 mRNA as determined by
in vitro competitive RT-PCR were used.
In situ RT-PCR was performed using
Thermus thermophilus DNA polymerase, special primer sets to form high molecular weight concatemers and an
in situ digoxigenin (DIG) direct labeling technique. Conventional ISH was performed using DIG-labeled cRNA probe. Specific signals of IL-6 mRNA were observed in the cytoplasm of positive cells by both
in situ RT-PCR and ISH.
In situ RT-PCR was more than 100-fold more sensitive than ISH. The specificity of
in situ RT-PCR was confirmed by appropriate control tests. The data indicated that the sensitivity of our
in situ RT-PCR applied to culture cells was significantly higher than that of ISH, and that the technique retained high specificity.
View full abstract